Small Glomeruli in WAGR (Wilms Tumor, Aniridia, Genitourinary Anomalies and Mental Retardation) Syndrome

American Journal of Kidney Diseases

Volumn 49, Issue 6, 2007, Pages 793-800

  Dahan, Karine ^a   Kamal, Maud ^b   Noël, Laure Hélène ^c   Jeanpierre, Cécile ^c   Gubler, Marie Claire ^c   Brousse, Nicole ^a   Mariaud de Serre, Natacha Patey ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c INSERM   (France)

Author keywords

kidney failure; WAGR syndrome; Wilms tumor; WT1

Indexed keywords

ANIRIDIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GLOMERULOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; KIDNEY FAILURE; MALE; MENTAL DEFICIENCY; NEPHROBLASTOMA; PRESCHOOL CHILD; UROGENITAL TRACT MALFORMATION; WAGR SYNDROME;

DENYS-DRASH SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; WAGR SYNDROME; WT1 PROTEINS;

EID: 34249064954     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.02.275     Document Type: Article

References (25)

1. Miller R.W., Fraumeni Jr. J.F., and Manning M.D. Association of Wilms's tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 270 (1924) 922-927
2. Riccardi V.M., Sujansky E., Smith A.C., and Francke U. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p Interstitial deletion. Pediatrics 61 (1978) 604-610
3. Francke U., Holmes L.B., Atkins L., and Riccardi V.M. Aniridia-Wilms' tumor association: Evidence for specific deletion of 11p13. Cytogenet Cell Genet 24 (1979) 185-192
4. Menke A., McInnes L., Hastie N.D., and Schedl A. The Wilms' tumor suppressor WT1: Approaches to gene function. Kidney Int 53 (1998) 1512-1518
5. Pritchard-Jones K., Fleming S., Davidson D., et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346 (1990) 194-197
6. Kreidberg J.A., Sariola H., Loring J.M., et al. WT-1 is required for early kidney development. Cell 74 (1993) 679-691
7. Drash A., Sherman F., Hartmann W.H., and Blizzard R.M. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76 (1970) 585-593
8. Habib R., Loirat C., Gubler M.C., et al. The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): A distinctive glomerular lesion-Report of 10 cases. Clin Nephrol 24 (1985) 269-278
9. Little M., and Wells C. A clinical overview of WT1 gene mutations. Hum Mutat 9 (1997) 209-225
10. Frasier S.D., Bashore R.A., and Mosier H.D. Gonadoblastoma associated with pure gonadal dysgenesis in monozygous twins. J Pediatr 64 (1964) 740-745
11. Moorthy A.V., Chesney R.W., and Lubinsky M. Chronic renal failure and XY gonadal dysgenesis: "Frasier" syndrome-A commentary on reported cases. Am J Med Genet Suppl 3 (1987) S297-S302
12. Gubler M.C., Yang Y., Jeanpierre C., Barbaux S., and Niaudet P. WT1, renal development, and glomerulopathies. Adv Nephrol Necker Hosp 29 (1999) 299-315
13. Breslow N.E., Takashima J.R., Ritchey M.L., Strong L.C., and Green D.M. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. Cancer Res 60 (2000) 4030-4032
14. Breslow N.E., Norris R., Norkool P.A., et al. Characteristics and outcomes of children with the Wilms tumor-aniridia syndrome: A report from the National Wilms Tumor Study Group. J Clin Oncol 21 (2003) 4579-4585
15. Breslow N.E., Collins A.J., Ritchey M.L., Grigoriev Y.A., Peterson S.M., and Green D.M. End stage renal disease in patients with Wilms tumor: Results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 174 (2005) 1972-1975
16. Merta M., Reiterova J., Krkavcova M., Rysava R., Kmentova D., and Tesar V. Focal segmental glomerulosclerosis in solitary kidney in WAGR syndrome. Prague Med Rep 105 (2004) 69-73
17. Malik K., Yan P., Huang T.H., and Brown K.W. Wilms' tumor: A paradigm for the new genetics. Oncol Res 12 (2000) 441-449
18. Fischbach B.V., Trout K.L., Lewis J., Luis C.A., and Sika M. WAGR syndrome: A clinical review of 54 cases. Pediatrics 116 (2005) 984-988
19. Malik K., Salpekar A., Hancock A., et al. Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor. Cancer Res 60 (2000) 2356-2360
20. Guo J.K., Menke A.L., Gubler M.C., et al. WT1 is a key regulator of podocyte function: Reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 11 (2002) 651-659
21. Amor D.J. Morbid obesity and hyperphagia in the WAGR syndrome. Clin Dysmorphol 11 (2002) 73-74
22. Tiberio G., Digilio M.C., and Giannotti A. Obesity and WAGR syndrome. Clin Dysmorphol 9 (2000) 63-64
23. Natoli T.A., Liu J., Eremina V., et al. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 13 (2002) 2058-2067
24. Little M.H., Williamson K.A., Mannens M., et al. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet 2 (1993) 259-264
25. Gubler M.C. WT1, a multiform protein. Contribution of genetic models to the understanding of its various functions. J Am Soc Nephrol 13 (2002) 2192-2194